{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"30"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"35"}],"units":"Participants"}],"groups":[{"description":"Induction:\n\nBortezomib (Velcade) 1.3 mg/m2/dose IV Days 1, 4, 8, 11 repeated every 21 days Dexamethasone 20 mg PO/IV Days 1, 4, 8, 11 repeated every 21 days\n\nConditioning:\n\nBortezomib 1.0 mg/m2/dose will be administered on Days +6, -3, +1, + 4 Melphalan 70-100 mg/m2/day IV on days -2 and -1\n\nBortezomib (Velcade) and Dexamethasone: Induction:\n\nVelcade 1.3 mg/m2/dose IV Days 1, 4, 8, 11 repeated every 21 days\n\nDexamethasone 20 mg PO/IV Days 1, 4, 8, 11 repeated every 21 days\n\nConditioning:\n\nBortezomib 1.0 mg/m2/dose will be administered on Days +6, -3, +1, + 4\n\nMelphalan 70-100 mg/m2/day IV on days -2 and -1","id":"OG000","title":"Bortezomib and Dexamethasone"}],"paramType":"COUNT_OF_PARTICIPANTS","reportingStatus":"POSTED","timeFrame":"2 months","title":"Number of Participants Proceeding to Transplant Following Induction","type":"PRIMARY","unitOfMeasure":"Participants"}